Antiviral Activity of CD437 Against Mumps Virus
Many efforts have been dedicated to the discovery of antiviral drug candidates against the mumps virus (MuV); however, no specific drug has yet been approved. The development of efficient screening methods is a key factor for the discovery of antiviral candidates. In this study, we evaluated a scree...
Guardado en:
Autores principales: | Fumihiro Kato, Yuichiro Nakatsu, Keiko Murano, Aika Wakata, Toru Kubota, Takayuki Hishiki, Toshiyuki Yamaji, Minoru Kidokoro, Hiroshi Katoh, Makoto Takeda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd9e9428311f4df4a3b2f70f310d8440 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection
por: Sara Mercader, et al.
Publicado: (2018) -
MODERN STATUS OF VACCINE PROPHYLAXIS OF MUMPS
por: E. O. Kontarova, et al.
Publicado: (2014) -
Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
por: Gupta Riya, et al.
Publicado: (2021) -
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
por: Jeffrey E. Gold, et al.
Publicado: (2020) -
VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
por: S. M. Kharit, et al.
Publicado: (2014)